Global & Regional Health Technology Assessment
AboutScience Srl
About the journal
Global & Regional Health Technology Assessment is an open-access journal published by AboutScience Srl in Italy, publishing in english and italian and spanish. It is listed in DOAJ according to the sources read. Declared publication charge: 1,500 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- AboutScience Srl
- ISSN
- 2284-2403 · 2283-5733
- Country
- Italy
- Languages
- english, italian, spanish
- Access
- Open access
- Declared publication charge
- 1,500 EUR
- Articles in DOAJ
- 393
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.aboutscience.eu/index.php/grhta/index
Index listings
- DOAJ · 2017-05-23
- Indexing
- DOAJ
- APC
- 1,500 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
393
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
460
Last recorded publication year
2026
h-index
10
i10-index
12
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2020-08-11
- Added to DOAJ
- 2017-05-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 90%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- GRHTAGlobal and regional health technology assessment
- Source type
- journal
- NLM unique ID (PubMed)
- 9918417986506676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
Show all subjects (50)
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Chronic Lymphocytic Leukemia Research
- Healthcare cost, quality, practices
- Healthcare cost, quality, practices
- Chronic Lymphocytic Leukemia Research
- Pharmaceutical Practices and Patient Outcomes
- Diabetes Treatment and Management
- Pharmaceutical Practices and Patient Outcomes
- Diabetes Treatment and Management
- Colorectal Cancer Treatments and Studies
- Epilepsy research and treatment
- Colorectal Cancer Treatments and Studies
- Epilepsy research and treatment
- Rheumatoid Arthritis Research and Therapies
- Diabetes Management and Research
- Lipoproteins and Cardiovascular Health
- Rheumatoid Arthritis Research and Therapies
- Inflammatory Bowel Disease
- Lipoproteins and Cardiovascular Health
- Diabetes Management and Research
- Asthma and respiratory diseases
- Inflammatory Bowel Disease
- Innovation Policy and R&D
- Innovation Policy and R&D
- Asthma and respiratory diseases
- Lung Cancer Treatments and Mutations
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Treatments and Mutations
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Intellectual Property and Patents
- Lymphoma Diagnosis and Treatment
- Autoimmune and Inflammatory Disorders Research
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Multiple Sclerosis Research Studies
- Autoimmune and Inflammatory Disorders Research
- Multiple Sclerosis Research Studies
- Lymphoma Diagnosis and Treatment
- Intellectual Property and Patents
Keywords (DOAJ)
- health technology assessment
- healthcare resources
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ